Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aon PLC (AON) vs Axogen Inc (AXGN) Price & Performance

Axogen IncTrade

Price performance (Past 24H)

Key statistics

Aon PLC vs Axogen Inc — how do they compare? Aon PLC trades at $351.67 (market cap $75.61B), while Axogen Inc trades at $49.11 (market cap $2.61B). The key difference: Aon PLC is far larger — about 29× Axogen Inc's market cap, and Aon PLC pays a 0.92% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.

AONAXGN
Market Cap
$75.61B$2.61B
Sector
FinancialsTechnology
52-Week High
$381.26$48.48
52-Week Low
$308.22$14.16
Enterprise Value
$90.22B$2.52B
Dividend Yield
0.92%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aon PLC

AON trades at $356.97, down 0.37% with neutral technical signals. The company shows strong fundamentals with Q2 2026 EPS beating estimates at $3.81 versus $3.80 expected, marking the third consecutive quarterly beat. Revenue growth accelerated to 5% organic in Q2 2026, while margins expanded 70 basis points. Analyst consensus price target stands at $410, representing 15% upside potential from current levels.

AON presents a compelling investment case with consistent earnings outperformance and robust profitability metrics including 44.88% ROE. However, premium valuation multiples and modest organic growth create headwinds. The stock offers 15% upside to consensus targets but requires monitoring of valuation compression risks amid competitive insurance brokerage markets.

Axogen Inc

AXGN trades at $48.53, up 0.64% today, with a bullish technical signal from moving averages and strong analyst support. Q2 2026 revenue grew 23.1% to $69.7M, beating estimates, and full-year guidance was raised to at least $279M. However, the company remains unprofitable with a net income margin of -13.36% and negative ROE, reflecting high SG&A costs relative to revenue.

The outlook is mixed: robust revenue growth and FDA-backed nerve care platform expansion offer upside, but persistent losses and high valuation multiples (P/S 9.57) pose risks. With 84% analyst buy ratings and a $54.33 price target, near-term momentum depends on execution toward profitability amid competitive and reimbursement pressures.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aon PLC

Aon is a leading global provider of insurance and reinsurance brokerage and human resource solutions. Its operations are tilted toward its brokerage operations. Headquartered in London, Aon has about 50,000 employees and operations in 120 countries around the world.

Read more on AON

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN